Dr. Ravel-Chapuis is an Assistant Professor in the School of Pharmaceutical Sciences at the University of Ottawa. He received his PhD from the Ecole Normale Supérieure de Lyon (France), focusing on the role of epigenetic modifications as regulators of gene expression in skeletal muscle. He next completed a postdoctoral fellowship at the University of Ottawa, studying the involvement of RNA-binding proteins in Myotonic Dystrophy type 1 (DM1).  Subsequently, he pursued his research as a research associate, characterizing cell signaling dysfunction in DM1 and developing new pharmacological approaches to improve the disease phenotype. In 2022, Dr. Ravel-Chapuis started a new independent research program at the University of Ottawa, investigating the role of the myosecretome in the context of DM1 and other neuromuscular disorders.